chr15_+_41136178
|
2.766
|
NM_003710
NM_181642
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1
|
chr12_-_58160823
|
2.420
|
NM_000785
|
CYP27B1
|
cytochrome P450, family 27, subfamily B, polypeptide 1
|
chr19_-_51456159
|
2.144
|
NM_001077491
NM_001077492
NM_012427
|
KLK5
|
kallikrein-related peptidase 5
|
chr2_+_47596286
|
2.041
|
NM_002354
|
EPCAM
|
epithelial cell adhesion molecule
|
chr19_-_10697907
|
1.945
|
NM_005498
|
AP1M2
|
adaptor-related protein complex 1, mu 2 subunit
|
chr1_+_26856259
|
1.859
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
chr1_+_26856252
|
1.623
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
chr1_-_209979388
|
1.604
|
NM_001206696
NM_006147
|
IRF6
|
interferon regulatory factor 6
|
chr19_+_38755097
|
1.563
|
NM_001166103
NM_021102
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2
|
chr19_+_38755422
|
1.540
|
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2
|
chr2_-_113594325
|
1.513
|
NM_000576
|
IL1B
|
interleukin 1, beta
|
chr1_+_26856240
|
1.468
|
NM_002953
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
chr11_+_62649160
|
1.452
|
|
SLC3A2
|
solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2
|
chr19_+_54371170
|
1.389
|
|
MYADM
|
myeloid-associated differentiation marker
|
chr1_+_183155173
|
1.375
|
NM_005562
NM_018891
|
LAMC2
|
laminin, gamma 2
|
chr11_+_18287807
|
1.344
|
NM_000331
NM_001178006
NM_199161
|
SAA1
|
serum amyloid A1
|
chr16_-_68269948
|
1.323
|
NM_024939
|
ESRP2
|
epithelial splicing regulatory protein 2
|
chr20_+_44637539
|
1.309
|
NM_004994
|
MMP9
|
matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)
|
chr17_-_7493389
|
1.303
|
NM_006942
|
SOX15
|
SRY (sex determining region Y)-box 15
|
chr11_-_18270167
|
1.279
|
NM_001199744
NM_001127380
NM_030754
|
SAA2-SAA4
SAA2
|
SAA2-SAA4 readthrough
serum amyloid A2
|
chr1_-_209825673
|
1.271
|
NM_001127641
|
LAMB3
|
laminin, beta 3
|
chr1_+_92495484
|
1.240
|
NM_173567
|
EPHX4
|
epoxide hydrolase 4
|
chr8_-_125740650
|
1.235
|
NM_014751
|
MTSS1
|
metastasis suppressor 1
|
chr12_+_41086189
|
1.200
|
NM_001843
NM_175038
|
CNTN1
|
contactin 1
|
chr1_-_209825797
|
1.182
|
NM_000228
|
LAMB3
|
laminin, beta 3
|
chr2_-_165424993
|
1.180
|
|
GRB14
|
growth factor receptor-bound protein 14
|
chr1_+_35247838
|
1.176
|
NM_001005752
|
GJB3
|
gap junction protein, beta 3, 31kDa
|
chr8_+_124194751
|
1.170
|
NM_032899
NM_207006
|
FAM83A
|
family with sequence similarity 83, member A
|
chr1_+_32042122
|
1.144
|
|
TINAGL1
|
tubulointerstitial nephritis antigen-like 1
|
chr19_+_35739282
|
1.140
|
|
LSR
|
lipolysis stimulated lipoprotein receptor
|
chr1_+_32042085
|
1.133
|
NM_001204414
NM_022164
|
TINAGL1
|
tubulointerstitial nephritis antigen-like 1
|
chr3_-_69435223
|
1.124
|
|
FRMD4B
|
FERM domain containing 4B
|
chr11_+_10482677
|
1.122
|
NM_001172430
|
AMPD3
|
adenosine monophosphate deaminase 3
|
chr8_+_95653340
|
1.114
|
NM_001034915
NM_001122825
NM_001122826
NM_001122827
NM_017697
|
ESRP1
|
epithelial splicing regulatory protein 1
|
chr2_+_17721806
|
1.081
|
NM_003385
|
VSNL1
|
visinin-like 1
|
chr1_+_32042125
|
1.074
|
|
TINAGL1
|
tubulointerstitial nephritis antigen-like 1
|
chr1_+_15250578
|
1.069
|
NM_001018000
|
KAZN
|
kazrin, periplakin interacting protein
|
chr19_-_36001336
|
1.064
|
NM_001126059
|
DMKN
|
dermokine
|
chr2_+_17721983
|
1.060
|
|
VSNL1
|
visinin-like 1
|
chr19_+_38755238
|
1.054
|
|
SPINT2
|
serine peptidase inhibitor, Kunitz type, 2
|
chr3_-_69435429
|
1.037
|
NM_015123
|
FRMD4B
|
FERM domain containing 4B
|
chr19_+_45312294
|
1.013
|
NM_001013257
NM_005581
|
BCAM
|
basal cell adhesion molecule (Lutheran blood group)
|
chr1_+_209848659
|
0.998
|
NM_015714
|
G0S2
|
G0/G1switch 2
|
chr8_+_95653399
|
0.985
|
|
ESRP1
|
epithelial splicing regulatory protein 1
|
chr17_-_27401216
|
0.965
|
|
TIAF1
|
TGFB1-induced anti-apoptotic factor 1
|
chr17_-_27401590
|
0.947
|
|
TIAF1
|
TGFB1-induced anti-apoptotic factor 1
|
chr1_+_1981902
|
0.938
|
NM_002744
|
PRKCZ
|
protein kinase C, zeta
|
chr1_+_117452359
|
0.936
|
NM_020440
|
PTGFRN
|
prostaglandin F2 receptor negative regulator
|
chr1_+_32043745
|
0.932
|
NM_001204415
|
TINAGL1
|
tubulointerstitial nephritis antigen-like 1
|
chr8_+_95653272
|
0.928
|
|
ESRP1
|
epithelial splicing regulatory protein 1
|
chr1_-_28520379
|
0.922
|
NM_001164721
NM_001164722
|
PTAFR
|
platelet-activating factor receptor
|
chr7_+_148036528
|
0.911
|
|
CNTNAP2
|
contactin associated protein-like 2
|
chr12_-_52867521
|
0.911
|
NM_173086
|
KRT6C
|
keratin 6C
|
chr18_-_28681885
|
0.908
|
NM_004949
NM_024422
|
DSC2
|
desmocollin 2
|
chr8_+_101170510
|
0.890
|
NM_003114
|
SPAG1
|
sperm associated antigen 1
|
chr9_-_33447527
|
0.866
|
NM_004925
|
AQP3
|
aquaporin 3 (Gill blood group)
|
chr14_+_65171243
|
0.863
|
|
PLEKHG3
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 3
|
chr2_+_95940195
|
0.859
|
NM_001165977
NM_001165978
NM_144707
|
PROM2
|
prominin 2
|
chr5_+_140186658
|
0.855
|
NM_018907
NM_031500
|
PCDHA4
|
protocadherin alpha 4
|
chr1_-_201368434
|
0.848
|
|
LAD1
|
ladinin 1
|
chr2_+_102608305
|
0.819
|
NM_004633
|
IL1R2
|
interleukin 1 receptor, type II
|
chr2_+_95940220
|
0.816
|
|
PROM2
|
prominin 2
|
chr5_+_66124603
|
0.815
|
NM_015183
|
MAST4
|
microtubule associated serine/threonine kinase family member 4
|
chr12_-_56881901
|
0.804
|
NM_013267
|
GLS2
|
glutaminase 2 (liver, mitochondrial)
|
chr14_+_65171149
|
0.802
|
NM_015549
|
PLEKHG3
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 3
|
chr19_+_54371125
|
0.795
|
NM_001020819
NM_138373
|
MYADM
|
myeloid-associated differentiation marker
|
chr1_-_153588789
|
0.782
|
NM_020672
|
S100A14
|
S100 calcium binding protein A14
|
chr17_-_39646115
|
0.774
|
NM_003771
|
KRT36
|
keratin 36
|
chr11_+_130029699
|
0.771
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
chr13_+_25254548
|
0.763
|
NM_001185085
NM_001676
|
ATP12A
|
ATPase, H+/K+ transporting, nongastric, alpha polypeptide
|
chr14_+_96671015
|
0.750
|
NM_000623
|
BDKRB2
|
bradykinin receptor B2
|
chr12_-_53298765
|
0.747
|
NM_002273
|
KRT8
|
keratin 8
|
chr1_-_160990862
|
0.737
|
|
F11R
|
F11 receptor
|
chr2_-_238499317
|
0.716
|
|
RAB17
|
RAB17, member RAS oncogene family
|
chr15_-_73661141
|
0.684
|
|
HCN4
|
hyperpolarization activated cyclic nucleotide-gated potassium channel 4
|
chr11_+_130029663
|
0.679
|
NM_021978
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
chr1_+_234040547
|
0.662
|
NM_173508
|
SLC35F3
|
solute carrier family 35, member F3
|
chr2_-_238499713
|
0.658
|
NM_022449
|
RAB17
|
RAB17, member RAS oncogene family
|
chr6_+_126070895
|
0.620
|
|
HEY2
|
hairy/enhancer-of-split related with YRPW motif 2
|
chr6_+_125474800
|
0.592
|
NM_001003396
NM_001003397
NM_003287
|
TPD52L1
|
tumor protein D52-like 1
|
chr6_+_18155535
|
0.585
|
NM_153042
|
KDM1B
|
lysine (K)-specific demethylase 1B
|
chr1_+_155099935
|
0.579
|
|
EFNA1
|
ephrin-A1
|
chr17_+_57297827
|
0.574
|
NM_001165993
NM_001165994
NM_182569
|
GDPD1
|
glycerophosphodiester phosphodiesterase domain containing 1
|
chr9_+_130911731
|
0.570
|
NM_005564
|
LCN2
|
lipocalin 2
|
chr5_+_176794312
|
0.565
|
|
RGS14
|
regulator of G-protein signaling 14
|
chr3_+_50192420
|
0.563
|
|
SEMA3F
|
sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F
|
chrX_-_31284946
|
0.552
|
NM_004015
NM_004016
NM_004017
NM_004018
NM_004019
|
DMD
|
dystrophin
|
chr13_+_37005966
|
0.552
|
NM_001111046
NM_001111047
|
CCNA1
|
cyclin A1
|
chr17_+_48610045
|
0.551
|
NM_017957
|
EPN3
|
epsin 3
|
chr14_-_24036939
|
0.545
|
|
AP1G2
|
adaptor-related protein complex 1, gamma 2 subunit
|
chr12_-_322612
|
0.527
|
NM_003044
NM_001122847
|
SLC6A12
|
solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12
|
chr9_+_131644780
|
0.523
|
NM_001127244
|
LRRC8A
|
leucine rich repeat containing 8 family, member A
|
chr17_-_3599487
|
0.516
|
NM_001204519
NM_001204520
NM_002561
NM_175080
|
P2RX5-TAX1BP3
P2RX5
|
P2RX5-TAX1BP3 readthrough
purinergic receptor P2X, ligand-gated ion channel, 5
|
chr19_+_45843997
|
0.515
|
NM_177417
|
KLC3
|
kinesin light chain 3
|
chr2_+_163200582
|
0.499
|
NM_012198
|
GCA
|
grancalcin, EF-hand calcium binding protein
|
chr5_-_35938736
|
0.496
|
NM_001042625
NM_144647
|
CAPSL
|
calcyphosine-like
|
chr4_-_36245893
|
0.495
|
NM_015230
|
ARAP2
|
ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 2
|
chr7_-_20256942
|
0.491
|
NM_182762
|
MACC1
|
metastasis associated in colon cancer 1
|
chr20_+_58630965
|
0.488
|
NM_173644
|
C20orf197
|
chromosome 20 open reading frame 197
|
chr15_+_40545348
|
0.488
|
|
PAK6
|
p21 protein (Cdc42/Rac)-activated kinase 6
|
chr11_+_60691911
|
0.484
|
NM_017870
NM_178031
|
TMEM132A
|
transmembrane protein 132A
|
chr19_-_11688508
|
0.483
|
NM_001611
|
ACP5
|
acid phosphatase 5, tartrate resistant
|
chr19_+_10381516
|
0.480
|
NM_000201
|
ICAM1
|
intercellular adhesion molecule 1
|
chr8_-_57232700
|
0.477
|
|
SDR16C5
|
short chain dehydrogenase/reductase family 16C, member 5
|
chr13_-_52980628
|
0.473
|
NM_018676
NM_199263
|
THSD1
|
thrombospondin, type I, domain containing 1
|
chr16_-_87903028
|
0.463
|
NM_003486
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
chr11_+_6866882
|
0.462
|
NM_178168
|
OR10A5
|
olfactory receptor, family 10, subfamily A, member 5
|
chr1_+_205473768
|
0.459
|
|
CDK18
|
cyclin-dependent kinase 18
|
chr6_+_150464156
|
0.457
|
NM_030949
|
PPP1R14C
|
protein phosphatase 1, regulatory (inhibitor) subunit 14C
|
chr20_-_23030141
|
0.455
|
NM_000361
|
THBD
|
thrombomodulin
|
chr19_+_10381763
|
0.453
|
|
ICAM1
|
intercellular adhesion molecule 1
|
chr6_-_13486986
|
0.453
|
|
GFOD1
|
glucose-fructose oxidoreductase domain containing 1
|
chr9_+_115913227
|
0.452
|
NM_001860
|
SLC31A2
|
solute carrier family 31 (copper transporters), member 2
|
chr19_-_51504799
|
0.450
|
NM_007196
NM_144505
NM_144506
NM_144507
|
KLK8
|
kallikrein-related peptidase 8
|
chr9_+_115913266
|
0.449
|
|
SLC31A2
|
solute carrier family 31 (copper transporters), member 2
|
chr1_-_201368617
|
0.448
|
NM_005558
|
LAD1
|
ladinin 1
|
chr2_+_163200623
|
0.447
|
|
GCA
|
grancalcin, EF-hand calcium binding protein
|
chr9_+_22446783
|
0.447
|
NM_022160
|
DMRTA1
|
DMRT-like family A1
|
chr4_-_40631846
|
0.446
|
NM_001098634
|
RBM47
|
RNA binding motif protein 47
|
chr18_+_55714457
|
0.445
|
NM_001144964
|
NEDD4L
|
neural precursor cell expressed, developmentally down-regulated 4-like
|
chr1_+_160370363
|
0.444
|
NM_020335
|
VANGL2
|
vang-like 2 (van gogh, Drosophila)
|
chr11_-_66488712
|
0.443
|
NM_006946
|
SPTBN2
|
spectrin, beta, non-erythrocytic 2
|
chr16_-_2031179
|
0.441
|
NM_172167
NM_172168
|
NOXO1
|
NADPH oxidase organizer 1
|
chrY_-_21154560
|
0.426
|
NM_013230
|
CD24
CD24P4
|
CD24 molecule
CD24 molecule pseudogene 4
|
chrX_+_102470003
|
0.419
|
NM_001080425
NM_001127688
|
BEX4
|
brain expressed, X-linked 4
|
chr10_-_120925157
|
0.419
|
NM_213649
|
SFXN4
|
sideroflexin 4
|
chr6_-_47009992
|
0.416
|
NM_025048
NM_153840
|
GPR110
|
G protein-coupled receptor 110
|
chr1_-_117210301
|
0.414
|
NM_001007237
NM_001542
|
IGSF3
|
immunoglobulin superfamily, member 3
|
chr1_-_201368716
|
0.411
|
|
LAD1
|
ladinin 1
|
chr3_-_12800739
|
0.411
|
NM_018306
|
TMEM40
|
transmembrane protein 40
|
chr11_-_118016134
|
0.411
|
NM_001142349
|
SCN4B
|
sodium channel, voltage-gated, type IV, beta
|
chr15_+_59730272
|
0.411
|
NM_152450
|
FAM81A
|
family with sequence similarity 81, member A
|
chr8_-_145669796
|
0.410
|
NM_013432
|
TONSL
|
tonsoku-like, DNA repair protein
|
chr8_+_124084936
|
0.410
|
|
WDR67
|
WD repeat domain 67
|
chr17_-_39768939
|
0.408
|
NM_005557
|
KRT16
|
keratin 16
|
chr11_+_62648340
|
0.407
|
NM_001013251
|
SLC3A2
|
solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2
|
chr13_-_52980234
|
0.405
|
|
THSD1
|
thrombospondin, type I, domain containing 1
|
chr7_-_16505292
|
0.403
|
NM_015464
|
SOSTDC1
|
sclerostin domain containing 1
|
chr10_-_131762017
|
0.400
|
NM_001005463
|
EBF3
|
early B-cell factor 3
|
chr11_+_130029712
|
0.398
|
|
ST14
|
suppression of tumorigenicity 14 (colon carcinoma)
|
chr19_+_54371150
|
0.394
|
|
MYADM
|
myeloid-associated differentiation marker
|
chr8_+_124084898
|
0.394
|
NM_001145088
NM_145647
|
WDR67
|
WD repeat domain 67
|
chr14_-_24037266
|
0.389
|
NM_003917
|
AP1G2
|
adaptor-related protein complex 1, gamma 2 subunit
|
chr19_+_39138349
|
0.387
|
|
ACTN4
|
actinin, alpha 4
|
chr6_-_13487772
|
0.386
|
NM_001242629
NM_018988
|
GFOD1
|
glucose-fructose oxidoreductase domain containing 1
|
chr6_+_80340971
|
0.377
|
NM_031469
|
SH3BGRL2
|
SH3 domain binding glutamic acid-rich protein like 2
|
chr14_-_24732344
|
0.375
|
NM_000359
|
TGM1
|
transglutaminase 1 (K polypeptide epidermal type I, protein-glutamine-gamma-glutamyltransferase)
|
chr6_+_125475334
|
0.373
|
NM_001003395
|
TPD52L1
|
tumor protein D52-like 1
|
chr5_+_36606667
|
0.371
|
|
SLC1A3
|
solute carrier family 1 (glial high affinity glutamate transporter), member 3
|
chr4_-_15939949
|
0.369
|
|
FGFBP1
|
fibroblast growth factor binding protein 1
|
chr11_-_85430382
|
0.366
|
NM_001162952
NM_206930
|
SYTL2
|
synaptotagmin-like 2
|
chr17_+_7342688
|
0.365
|
NM_004112
|
FGF11
|
fibroblast growth factor 11
|
chr3_+_142442855
|
0.363
|
|
|
|
chr15_+_66679107
|
0.358
|
NM_002755
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
chr16_+_27325269
|
0.357
|
|
IL4R
|
interleukin 4 receptor
|
chr15_+_66694216
|
0.357
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
chr1_+_24649529
|
0.350
|
NM_021180
|
GRHL3
|
grainyhead-like 3 (Drosophila)
|
chr2_-_142889269
|
0.348
|
NM_018557
|
LRP1B
|
low density lipoprotein receptor-related protein 1B
|
chr17_-_41322211
|
0.346
|
|
BRCA1
|
breast cancer 1, early onset
|
chr18_+_12254317
|
0.345
|
NM_001279
|
CIDEA
|
cell death-inducing DFFA-like effector a
|
chr8_-_66754276
|
0.344
|
|
PDE7A
|
phosphodiesterase 7A
|
chr16_+_27325244
|
0.343
|
NM_000418
NM_001008699
|
IL4R
|
interleukin 4 receptor
|
chr7_+_26191732
|
0.342
|
NM_004289
|
NFE2L3
|
nuclear factor (erythroid-derived 2)-like 3
|
chr16_+_30194730
|
0.342
|
NM_001193333
NM_007074
|
CORO1A
|
coronin, actin binding protein, 1A
|
chr14_-_21572374
|
0.341
|
|
|
|
chr15_+_42120155
|
0.340
|
NM_001114632
NM_001198588
NM_005090
|
JMJD7
JMJD7-PLA2G4B
|
jumonji domain containing 7
JMJD7-PLA2G4B readthrough
|
chr9_+_12693385
|
0.338
|
NM_000550
|
TYRP1
|
tyrosinase-related protein 1
|
chr6_+_126070738
|
0.337
|
|
HEY2
|
hairy/enhancer-of-split related with YRPW motif 2
|
chr1_-_116311330
|
0.336
|
|
CASQ2
|
calsequestrin 2 (cardiac muscle)
|
chr16_-_71264557
|
0.335
|
NM_032821
NM_017558
|
HYDIN
|
hydrocephalus inducing homolog (mouse)
|
chr11_+_117947726
|
0.334
|
NM_001083947
NM_001173551
NM_001173552
NM_019894
|
TMPRSS4
|
transmembrane protease, serine 4
|
chr17_+_48610077
|
0.334
|
|
EPN3
|
epsin 3
|
chr7_+_89783688
|
0.330
|
NM_012449
|
STEAP1
|
six transmembrane epithelial antigen of the prostate 1
|
chr14_+_39703119
|
0.329
|
NM_054024
|
MIA2
|
melanoma inhibitory activity 2
|
chr1_-_85462622
|
0.328
|
NM_153259
|
MCOLN2
|
mucolipin 2
|
chr2_+_206547131
|
0.324
|
NM_003872
NM_018534
NM_201264
NM_201266
NM_201267
NM_201279
|
NRP2
|
neuropilin 2
|
chr20_+_35201854
|
0.322
|
NM_001199513
NM_001199514
|
TGIF2
|
TGFB-induced factor homeobox 2
|
chr2_+_96931988
|
0.322
|
|
CIAO1
|
cytosolic iron-sulfur protein assembly 1
|
chr1_-_26680620
|
0.322
|
NM_001039775
|
AIM1L
|
absent in melanoma 1-like
|
chr4_-_153456152
|
0.320
|
NM_033632
|
FBXW7
|
F-box and WD repeat domain containing 7
|
chr1_+_100326765
|
0.320
|
NM_000645
|
AGL
|
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase
|
chr1_+_209602164
|
0.317
|
NM_001104548
|
MIR205HG
|
MIR205 host gene (non-protein coding)
|
chr4_+_81256873
|
0.315
|
NM_001206997
NM_152770
|
C4orf22
|
chromosome 4 open reading frame 22
|
chr2_+_97426571
|
0.314
|
NM_020184
|
CNNM4
|
cyclin M4
|
chr6_+_132859426
|
0.311
|
NM_175057
|
TAAR9
|
trace amine associated receptor 9 (gene/pseudogene)
|
chr16_-_11680146
|
0.310
|
NM_004862
|
LITAF
|
lipopolysaccharide-induced TNF factor
|
chr1_+_110577219
|
0.309
|
NM_033088
|
FAM40A
|
family with sequence similarity 40, member A
|
chr1_-_54303933
|
0.307
|
|
TMEM48
|
transmembrane protein 48
|
chr15_-_52587851
|
0.306
|
NM_018728
|
MYO5C
|
myosin VC
|
chr16_+_23690234
|
0.305
|
|
PLK1
|
polo-like kinase 1
|
chr16_-_23652477
|
0.304
|
NM_024675
|
PALB2
|
partner and localizer of BRCA2
|
chr19_-_43098980
|
0.303
|
NM_001816
|
CEACAM8
|
carcinoembryonic antigen-related cell adhesion molecule 8
|
chr10_+_103911932
|
0.302
|
NM_004741
|
NOLC1
|
nucleolar and coiled-body phosphoprotein 1
|
chr20_-_1309809
|
0.301
|
NM_080489
|
SDCBP2
|
syndecan binding protein (syntenin) 2
|
chr11_+_1860232
|
0.301
|
NM_003282
|
TNNI2
|
troponin I type 2 (skeletal, fast)
|
chr2_+_16080559
|
0.300
|
|
MYCN
|
v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)
|
chr18_-_19284622
|
0.298
|
|
ABHD3
|
abhydrolase domain containing 3
|
chr5_+_72861567
|
0.296
|
NM_032175
|
UTP15
|
UTP15, U3 small nucleolar ribonucleoprotein, homolog (S. cerevisiae)
|
chr21_-_31538970
|
0.289
|
NM_012131
|
CLDN17
|
claudin 17
|
chr11_+_119039415
|
0.288
|
NM_024618
NM_170722
|
NLRX1
|
NLR family member X1
|